The effects of methamphetamine on the production of free radicals and oxidative stress

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 1, 1998, Pages 107-114

  Yamamoto, Bryan K ^a,b   Zhu, Wenjun ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDROXYBENZOIC ACID; DEFEROXAMINE; FREE RADICAL; MALONALDEHYDE; METHAMPHETAMINE; PHENYLALANINE; REACTIVE OXYGEN METABOLITE; SALICYLIC ACID DERIVATIVE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; LIPID PEROXIDATION; MALE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS STRIATUM; DEFEROXAMINE; DOPAMINE; HYDROXYL RADICAL; IRON; LIPID PEROXIDATION; MALE; METHAMPHETAMINE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; URIC ACID;

EID: 0032462195     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Abekawa T, Ohmori T and Koyama T (1994) Effects of repeated administration of high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res 643:276-281, 1994.
2. Ames BN, Cathcart R, Schwiers E and Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci 78:6855-6862.
3. Ben-Shachar D and Youdim MBH (1990) Selectivity of melanized nigra-striatal dopamine neurons to degeneration in Parkinson's disease may depend on iron-melanin interaction. J Neural Transm Suppl 29:251-258.
4. Ben-Shachar D and Youdim MBH (1991) Intranigral iron injection induces behavioral and biochemical "Parkinsonism" in rats. J Neurochem 57:2133-2135.
5. Bondy SC and Lee DK (1993) Oxidative stress induced by glutamate receptor agonists. Brain Res 610:229-233.
6. Bowyer JF, Clausing P, Schmued L, Davies DL, Binienda Z, Newport GD, Scallet AC and Slikker JR, W (1996) Parenterally administered 3-nitroproprionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum. Brain Res 712:221-229.
7. Bowyer JF, Tank AW, Newport GD, Slikker W, Ali SF and Holson RR (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharm Exp Ther 260:817-824.
8. Cadet JL, Sheng P, Ali S, Rothman R, Carlson E and Epstein C (1994) Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurochem 62:380-383.
9. Cappon GD, Broening HW, Pu C, Morford L and Vorhees CV (1996) α-Phenyl-N-tert-butyl nitrone attenuates roethamphetamine-induced depletion of striatal dopamine without altering hyperthermia. Synapse 24:173-181.
10. Che S, Johnson M, Hanson GR and Gibb JW (1995) Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity. Eur J Pharmacol 293:447-453.
11. Cini M, Fariello RG, Bianchetti A and Moretti A (1994) Studies on lipid peroxidation in the rat brain. Neurochem Res 19:283-288.
12. Colado MI, O'Shea E, Granados R, Murray TK and Green AR (1997) In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ("ecstasy") and p-chloramphetamine but not the degeneration following fenfluramine. Br J Pharmacol 121:889-900.
13. Cubells JF, Rayport S, Rajendran G and Sulzer D (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci 14:2260-2271.
14. Dawson TM, Dawson VL and Snyder SH (1992) A novel neuronal messenger molecule in the brain: The free radical, nitric oxide. Annals Neurol 32:297-311.
15. Devito MJ and Wagner GC (1989) Methamphetamine-induced neuronal damage: A possible role for free radicals. Neuropharmacology 28:1145-1150.
16. Dexter DT, Wells FR, Agid F, Agid Y, Lees A, Jenner P and Marsden CD (1989a) Increased nigral iron content and alteration in other metals occurring in Parkinson's disease. J Neurochem 52:1830-1836.
17. Draper HH and Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Meth Enzymol 186:421-431.
18. Dugan LL, Sensi SL, Canzoniero LM, Handran SD, Rothman SM, Lin TS, Goldberg MP and Choi DW (1995) Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J Neurosci 15:6377-6388.
19. Dumuis A, Sebben M, Haynes L, Pin JP and Bockaert J (1988) NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature (Lond) 336:68-70.
20. Farfel GM and Seiden LS (1995a) Role of hypothermia in mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX. J Pharmacol Exp Ther 272:860-867.
21. Farfel GM and Seiden LS (1995b) Role of hypothermia in mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. J Pharmacol Exp Ther 272:868-875.
22. Filloux F and Townsend JJ (1993) Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp Neurology 119:79-88.
23. Heckenstein AE, Metzger RR, Beyeler ML, Gibb JW and Hanson GR (1997a) Oxygen radicals diminish dopamine transporter function in rat striatum. Eur J Pharmacol 334:111-114.
24. Fleckenstein AE, Metzger RR, Gibb JW and Hanson GR (1997d) A rapid and reversible change in dopamine transporters induced by methamphetamine. Eur J Pharmacol 323:R9-10.
25. Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JW and Hanson GR (1997c) Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther 282:834-838.
26. Fleckenstein AE, Wilkins DG, Gibb JW and Hanson GR (1997b) Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J Pharmacol Exp Ther 283:281-285.
27. Floyd RA and Carney JM (1992) Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neural 32:S22-S27.
28. Gibb JW and Kogan FJ (1979) Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity. Naunyn-Schmiedeberg's Arch Pharmacol 310:185-187.
29. Giovanni A, Liang LP, Hastings TG and Zigmond MJ (1995) Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: Impact of methamphetamine. J Neurochem 64:1819-1825.
30. Grootveld M and Halliwell B (1987) Measurement of allantoin and uric acid in human body fluids. A potential index of free-radical reactions in vivo? Biochem J 243:803-808.
31. Gutteridge JMC and Halliwell B (1990) The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 15:129-135.
32. Halliwell B, Grootveld M, Kaur H and Fagerheim I (1988) Aromatic hydroxylation and uric acid degradation as methods for detecting and measuring oxygen radicals in vivo and in vitro, in Free Radicals: Methodology and Concepts (Rice-Evans C and Halliwell B, eds) pp 33-59, Richelieu Press, London.
33. Hirata H, Ladendeim B, Carlson E, Epstein C and Cadet JL (1996) Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: Attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res 714:95-103.
34. Hirsch EC, Brandel JP, Galle P, Javoy-Agid F and Agid Y (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: An x-ray microanalysis. J Neurochem 56:446-452.
35. Huie RE and Padmaja S (1993) The reaction of NO with duperoxide. Free Rad Res Comm 18:195-199.
36. Kaur H and Halliwell B (1994) Detection of hydroxyl radicals by aromatic hydroxylation. Meth Enzymol 233:67-82.
37. Kondo T, Ito T and Sugita Y (1994) Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuated dopamine depletion in mouse striatum. Ann NY Acad Sci 738:222-229.
38. Kopin IJ (1992) The pharmacology of Parkinson's disease therapy. An update. Ann Rev Pharmacol Toxicol 32:467-495.
39. Lafon-Cazal M, Pietri S, Culcasi M and Bockaert J (1993) NMDA-dependent superoxide production and neurotoxicity. Nature (Lond) 364:535-537.
40. Maples ICR and Mason RP (1988) Free radical metabolite of uric acid. J Biol Chem 263:1709-1712.
41. McCord JM (1985) Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159-163.
42. Michel PP and Hefti F (1990) Toxicity of 6-hyroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res 26:428-435.
43. Miller DB and O'Callaghan JP (1994) Environment-, drug-, and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:752-760.
44. Nash JF and Yamamoto BK (1992) Methamphetamine neurotoxicity and striatal glutamate release: Comparison to 3,4-methylenedioxymethamphetamine. Brain Res 581:237-243.
45. Olanow CF (1992) An introduction to the free radical hypothesis in Parkinson's disease. Ann Neurol 32:S2-S9.
46. Olanow CW (1990) Oxidation reactions in Parkinson's disease. Neurology 40:32-37.
47. Olanow CW (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16:439-444.
48. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
49. Riederer P, Sofic E, Rausch W, Schmidt B, Reynolds GP, Jellinger K and Youdim MBH (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52:515-520.
50. Rosenberg PA (1988) Catecholamine toxicity in cerebral cortex in dissociated cell culture. J Neurosci 8:2887-2894.
51. Sakamoto A, Ohnishi ST, Ohnishi T and Ogawa R (1991) Relationship between free radical production and lipid peroxidation during ischemia-reperfusion injury in the rat brain. Brain Res 554:186-192.
52. Schmidt CJ, Ritter JK, Sonsalla PK, Hanson GR and Gibb JW (1985) Role of dopamine in the neurotoxic effects of methamphetamine. J Pharmacol Exp Ther 233:539-544.
53. Seiden LS and Ricaurte GA (1987) Neurotoxicity of methamphetamine and related drugs, in Psychopharmacology: The Third Generation of Progress, (Meltzer HY, ed) pp 359-366, Raven Press, New York.
54. Sofic E, Paulus W, Jellinger K, Riederer P and Youdim MBH (1991) Selective increase of iron in the substantia nigra zona compacta of parkinsonian brains. J Neurochem 56:978-982.
55. Sonsalla PK, Nicklas WJ and Heikkila RE (1989) Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243:398-400.
56. Sonsalla PK, Riordan DE and Heikkila RE (1991) Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J Pharmacol Exp Ther 256:506-512.
57. Stephans SE and Yamamoto BK (1994) Methamphetamine-induced neurotoxicity: Roles for glutamate and dopamine efflux. Synapse 17:203-209.
58. Stephans SE and Yamamoto BK (1996) Methamphetamine pretreatment and the vulnerability of the striatum to methamphetamine toxicity. Neuroscience 72:593-600.
59. Stone DM, Hanson GR and Gibb JW (1989b) In vitro reactivation of rat cortical tryptophan hydroxylase following in vivo inactivation by methylenedioxymethamphetamine. J Neurochem 53:572-581.
60. Stone DM, Johnson M, Hanson GR and Gibb JW (1989a) Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites. Eur J Pharmacol 172:93-97.
61. Sun J, Kaur H, Halliwell B, Li X Bolli R (1993) Use of aromatic hydroxylation of phenylalanine to measure production of hydroxyl radicals after myocardial ischemia in vivo: Direct evidence for a pathogenetic role of the hydroxyl radical in myocardial stunning. Circ Res 73:534-549.
62. Tanaka M, Sotomatsu A, Kanai H and Hirai S (1991) Dopa and dopamine cause cultured neuronal death in the presence of iron. J Neurol Sci 101:198-203.
63. Valenzuela A (1991) The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress. Life Sci 48:301-309.
64. Wagner GC, Carelli RM and Jarvis MF (1985) Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Res Comm Chem Pathol Pharm 47:221-228.
65. Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ and Westley J (1980) Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181:151-160.
66. Yamamoto BK and Pehek EA (1990) A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis. Brain Res 506:236-242.